15 Feb 2017 TapImmune Advances TPIV 200 Phase 2 Triple-Negative Breast Cancer Trial After Favorable DSMB Review
14 Feb 2017 Vaxart Announces Positive Phase 1 Study of Oral Norovirus Vaccine
14 Feb 2017 Allergy Therapeutics PLC Announces Novel House Dust Mite Allergy Vaccine Gains Clinical Trial Application Approval
06 Feb 2017 NW Bio Announces Lifting of Clinical Hold on DCVax®-L Phase III Trial By FDA; Progression-Free Survival Events Reached; Overall Survival Events Not Yet Reached
06 Feb 2017 Advaxis Announces First Patient Dosed in Global Phase 3 AIM2CERV Trial for High-risk, Locally Advanced Cervical Cancer
02 Feb 2017 Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients
27 Jan 2017 Latest Clinical Data from OncBioMune Supports Safety and Therapeutic Profile of ProscaVax for Prostate Cancer for Upcoming Phase 2 Clinical Trials
26 Jan 2017 Pfizer Announces Positive Top-Line Results from Phase 2 Study of Investigational Clostridium difficile Vaccine for the Prevention of C. difficile Infection
25 Jan 2017 OSE Immunotherapeutics Announces That the Independent Data Monitoring Committee (IDMC) Recommends Continuation of Pivotal Phase 3 Clinical Trial of Tedopi® in Non-Small Cell Lung Cancer
24 Jan 2017 GeoVax Announces Initiation of HIV Human Clinical Trial
18 Jan 2017 GeoVax to collaborate with Georgia State on development of hepatitis B therapeutic vaccine
18 Jan 2017 Agenus announces collaboration with the National Cancer Institute to evaluate the combination of Pembrolizumab (Keytruda®, Merck & Co., Inc.) with Prophage™ (Agenus Inc.) autologous vaccine
13 Jan 2017 Sanaria's PfSPZ Vaccine Provides High Level Defense Against Malaria In U.S. Navy and Army Clinical Investigation
13 Jan 2017 Protein Sciences Zika Vaccine Shows Good Results in Preclinical Testing
09 Jan 2017 Aduro Biotech Announces Clinical Collaboration with Merck to Evaluate the Combination of Aduro’s CRS-207 with Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Gastric Cancer
04 Jan 2017 Bavarian Nordic Provides Update on Anticipated Timing of PROSPECT Study
04 Jan 2017 Bavarian Nordic Initiates Trial of CV301 in Combination with Nivolumab in Patients with Lung Cancer
23 Dec 2016 Gradalis Announces a Novel Combination Study of Vigil® EATC
22 Dec 2016 Inovio’s Zika Vaccine Generates Robust Immune Responses in First Human Study
21 Dec 2016 Astellas Announces FDA Fast Track Designation for ASP0892, DNA Vaccine for Mitigation of Severe Hypersensitivity Reactions Due to Peanut Allergy
19 Dec 2016 Pfizer Receives Approval in the European Union for Nimenrix™ (Meningococcal Group A, C, W-135, and Y Conjugate Vaccine) in Infants Six Weeks of Age and Older
13 Dec 2016 Zika virus: top EU-groups join forces in quest for vaccine
11 Dec 2016 AXON’s Alzheimer Tau Vaccine Phase 1 Study Results Published in Lancet Neurology
09 Dec 2016 NW Bio Provides Update About Phase 3 Trial Of DCVax®-L for Newly Diagnosed Glioblastoma Multiforme Brain Cancer
09 Dec 2016 Valneva Receives FDA and European Approvals to Start Clinical Testing of Lyme Disease Vaccine Candidate

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing